2023 Q1 Form 10-K Financial Statement

#000190359623000201 Filed on March 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $89.00K $108.0K $450.00
YoY Change -14.42% 13.52% -99.87%
Cost Of Revenue $53.00K $53.00K $220.00
YoY Change 3.92% 41.64% -99.85%
Gross Profit $36.00K $55.00K $230.00
YoY Change -32.08% -4.71% -99.89%
Gross Profit Margin 40.45% 50.93% 51.11%
Selling, General & Admin $2.073M $2.537M $8.003K
YoY Change -25.4% 52.3% -99.9%
% of Gross Profit 5758.33% 4612.73% 3479.57%
Research & Development $1.525M $2.018M $7.557K
YoY Change -25.72% 1093.87% -95.53%
% of Gross Profit 4236.11% 3669.09% 3285.65%
Depreciation & Amortization $293.0K $405.0K $405.0K
YoY Change
% of Gross Profit 813.89% 736.36% 176086.96%
Operating Expenses $3.598M $4.555M $16.46K
YoY Change -36.48% -2.38% -99.98%
Operating Profit -$3.562M -$4.500M $16.23K
YoY Change -36.52% -2.35% -100.02%
Interest Expense $46.00K -$295.0K $417.00
YoY Change -43.21% 65.64% -100.01%
% of Operating Profit 2.57%
Other Income/Expense, Net $411.0K $35.00K $47.00
YoY Change 448.0% -96.62% -100.0%
Pretax Income -$3.151M -$4.760M $16.28K
YoY Change -42.24% 26.89% -100.02%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.151M -$4.760M $16.28K
YoY Change -42.24% 26.89% -100.02%
Net Earnings / Revenue -3540.45% -4407.41% 3618.0%
Basic Earnings Per Share -$0.22 -$1.00
Diluted Earnings Per Share -$0.22 -$0.29 -$1.00
COMMON SHARES
Basic Shares Outstanding 18.44M shares 16.41M shares 16.25M shares
Diluted Shares Outstanding 17.85M shares 16.25M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.067M $3.462M $3.462M
YoY Change -79.91% 43013.33% 43013.33%
Cash & Equivalents $2.067M $3.462K
Short-Term Investments
Other Short-Term Assets $2.645M $912.0K $912.0K
YoY Change 212.65% 58.81% 58.81%
Inventory
Prepaid Expenses $589.0K $183.00
Receivables $63.00K $51.00 $51.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.775M $4.425K $4.425M
YoY Change -57.29% -99.29% 610.67%
LONG-TERM ASSETS
Property, Plant & Equipment $112.0K $127.0K $127.0K
YoY Change -35.26% -32.68% -32.68%
Goodwill $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.529M $2.709M $2.709M
YoY Change -17.57% -17.4% -17.4%
Total Long-Term Assets $7.606M $8.094K $8.094M
YoY Change 10.36% -99.88% 16.72%
TOTAL ASSETS
Total Short-Term Assets $4.775M $4.425K $4.425M
Total Long-Term Assets $7.606M $8.094K $8.094M
Total Assets $12.38M $12.52K $12.52M
YoY Change -31.49% -99.83% 65.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $461.0K $347.00 $347.0K
YoY Change -2.74% -99.97% -72.35%
Accrued Expenses $1.163M $1.870K $1.934M
YoY Change -38.3% -99.94% -39.51%
Deferred Revenue
YoY Change
Short-Term Debt $281.0K $1.785M $1.785M
YoY Change -84.09% -0.9% -0.9%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.377M $4.929K $4.929M
YoY Change -52.63% -99.93% -32.32%
LONG-TERM LIABILITIES
Long-Term Debt $67.00K $67.00K $67.00K
YoY Change 0.0% -0.59% -0.59%
Other Long-Term Liabilities $80.00K $99.00K $99.00K
YoY Change -96.47% -39.3% -39.3%
Total Long-Term Liabilities $147.0K $166.00 $166.0K
YoY Change -93.7% -99.93% -27.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.377M $4.929K $4.929M
Total Long-Term Liabilities $147.0K $166.00 $166.0K
Total Liabilities $2.524M $5.095K $5.095M
YoY Change -65.67% -99.93% -32.18%
SHAREHOLDERS EQUITY
Retained Earnings -$144.4M $140.5K
YoY Change -100.11%
Common Stock $19.00K $17.00
YoY Change -99.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.857M $7.424K $7.424M
YoY Change
Total Liabilities & Shareholders Equity $12.38M $12.52K $12.52M
YoY Change -31.49% -99.83% 65.66%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$3.151M -$4.760M $16.28K
YoY Change -42.24% 26.89% -100.02%
Depreciation, Depletion And Amortization $293.0K $405.0K $405.0K
YoY Change
Cash From Operating Activities -$3.050M -$2.452M $8.199K
YoY Change 5.98% 144.3% -100.45%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $41.00K $1.789M
YoY Change -100.0% -89.51% -252.02%
Acquisitions
YoY Change
Other Investing Activities -$2.000K -$2.000K
YoY Change -75.0%
Cash From Investing Activities $0.00 -$43.00K $1.791K
YoY Change -100.0% -111.01% -100.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $2.982M 79.00K $13.44K
YoY Change -77.65% -86.8% -99.55%
NET CHANGE
Cash From Operating Activities -$3.050M -2.452M $8.199K
Cash From Investing Activities $0.00 -43.00K $1.791K
Cash From Financing Activities $2.982M 79.00K $13.44K
Net Change In Cash -$68.00K -2.416M $23.43K
YoY Change -100.66% 16596.61% -147.37%
FREE CASH FLOW
Cash From Operating Activities -$3.050M -$2.452M $8.199K
Capital Expenditures $0.00 $41.00K $1.789M
Free Cash Flow -$3.050M -$2.493M -$1.781M
YoY Change 13.26% 78.79% 174.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001070050
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 apcx Prepaid Offering Cost
PrepaidOfferingCost
usd
CY2021Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 apcx Common Stock Cancelled Amount
CommonStockCancelledAmount
usd
CY2021 apcx Common Stock Issued For Forbearances Two
CommonStockIssuedForForbearancesTwo
usd
CY2022 apcx Stock Issued For Exercise Of Warrants
StockIssuedForExerciseOfWarrants
usd
CY2022 apcx Stock Issued For Purchase Of Judgment
StockIssuedForPurchaseOfJudgment
usd
CY2022 apcx Excess Fair Market Value Of Shares Issued Recorded As Interest Expense
ExcessFairMarketValueOfSharesIssuedRecordedAsInterestExpense
usd
CY2022 apcx Imputed Interest On Notes Payable
ImputedInterestOnNotesPayable
usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2022 apcx Increase Decrease In Right Of Use Asset And Liability
IncreaseDecreaseInRightOfUseAssetAndLiability
usd
CY2021 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
usd
CY2022 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
usd
CY2022 apcx Payments For Prepaid Offering Costs
PaymentsForPrepaidOfferingCosts
usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
CY2021 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
usd
CY2021 apcx Offering Costs Paid
OfferingCostsPaid
usd
CY2021 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
usd
CY2021 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
usd
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
usd
CY2022 us-gaap Proceeds From Repurchase Of Redeemable Preferred Stock
ProceedsFromRepurchaseOfRedeemablePreferredStock
usd
CY2021 apcx Common Stock Issued For Forbearances One
CommonStockIssuedForForbearancesOne
usd
CY2022 apcx Common Stock Issued For Conversion Of Accounts Payable
CommonStockIssuedForConversionOfAccountsPayable
usd
CY2022 apcx Common Stock Issued Convertible Notes Accrued Interest And Derivative Liabilities
CommonStockIssuedConvertibleNotesAccruedInterestAndDerivativeLiabilities
usd
CY2021 apcx Relief Of Antidilution Liability Through Issuance Of Common Stock
ReliefOfAntidilutionLiabilityThroughIssuanceOfCommonStock
usd
CY2021 apcx Issuance Of Stock For Prepaid Services
IssuanceOfStockForPrepaidServices
usd
CY2021 apcx Issuance Of Stock For Intangible Assets
IssuanceOfStockForIntangibleAssets
usd
CY2022 apcx Common Stock And Options Issued For Capitalized Software And Licensing Costs
CommonStockAndOptionsIssuedForCapitalizedSoftwareAndLicensingCosts
usd
CY2022 apcx Common Stock Issued With Forbearance Agreements Recorded As Discount
CommonStockIssuedWithForbearanceAgreementsRecordedAsDiscount
usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
usd
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
usd
CY2021 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
usd
CY2021 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-27569
CY2022 dei Entity Registrant Name
EntityRegistrantName
AppTech Payments Corp.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
66-0847995
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
5876 Owens Avenue
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Carlsbad
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92008
CY2022 dei City Area Code
CityAreaCode
760
CY2022 dei Local Phone Number
LocalPhoneNumber
707-5959
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
8270261 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18438947 shares
CY2022 dei Auditor Name
AuditorName
dbbmckennon
CY2022 dei Auditor Firm
AuditorFirmId
3501
CY2022 dei Auditor Location
AuditorLocation
San Diego, California
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3462 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
40 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
183 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
95 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
729 usd
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
479 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4425 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
622 usd
CY2021Q4 apcx Prepaid Offering Cost
PrepaidOfferingCost
92 usd
CY2022Q4 us-gaap Prepaid Expense Other Noncurrent
PrepaidExpenseOtherNoncurrent
2700 usd
CY2021Q4 us-gaap Prepaid Expense Other Noncurrent
PrepaidExpenseOtherNoncurrent
3180 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
311 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
26 usd
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
26 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
127 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
189 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
9 usd
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8 usd
CY2022Q4 apcx Capitalized Prepaid Software Development And License
CapitalizedPrepaidSoftwareDevelopmentAndLicense
4921 usd
CY2021Q4 apcx Capitalized Prepaid Software Development And License
CapitalizedPrepaidSoftwareDevelopmentAndLicense
3440 usd
CY2022Q4 us-gaap Assets
Assets
12519 usd
CY2021Q4 us-gaap Assets
Assets
7557 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
347 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1255 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1870 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3136 usd
CY2022Q4 apcx Stock Repurchase Liability
StockRepurchaseLiability
430 usd
CY2021Q4 apcx Stock Repurchase Liability
StockRepurchaseLiability
430 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
51 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
676 usd
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
679 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1021 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
438 usd
CY2022Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
88 usd
CY2021Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
685 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
433 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
599 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
64 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
61 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4929 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7283 usd
CY2022Q4 apcx Right Of Use Liability
RightOfUseLiability
99 usd
CY2021Q4 apcx Right Of Use Liability
RightOfUseLiability
163 usd
CY2022Q4 apcx Notes Payable Net Of Current Portion
NotesPayableNetOfCurrentPortion
67 usd
CY2021Q4 apcx Notes Payable Net Of Current Portion
NotesPayableNetOfCurrentPortion
67 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
166 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
230 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5095 usd
CY2021Q4 us-gaap Liabilities
Liabilities
7513 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10526 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10526 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
14 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
14 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
14 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
14 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
105263158 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
105263158 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16697280 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11944600 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
17 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
147881 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
124225 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
140474 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124193 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7424 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
44 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12519 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7557 usd
CY2022 us-gaap Revenues
Revenues
450 usd
CY2021 us-gaap Revenues
Revenues
354 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
220 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
150 usd
CY2022 us-gaap Gross Profit
GrossProfit
230 usd
CY2021 us-gaap Gross Profit
GrossProfit
204 usd
CY2022 apcx Stock Based Compensation Including Selling General And Administrative
StockBasedCompensationIncludingSellingGeneralAndAdministrative
1547 usd
CY2021 apcx Stock Based Compensation Including Selling General And Administrative
StockBasedCompensationIncludingSellingGeneralAndAdministrative
6334 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8003 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8399 usd
CY2022 apcx Excess Fair Value Of Equity Issuance Over Assets Received
ExcessFairValueOfEquityIssuanceOverAssetsReceived
904 usd
CY2021 apcx Excess Fair Value Of Equity Issuance Over Assets Received
ExcessFairValueOfEquityIssuanceOverAssetsReceived
68956 usd
CY2022 apcx Stock Based Compensation Including Research And Development
StockBasedCompensationIncludingResearchAndDevelopment
6158 usd
CY2021 apcx Stock Based Compensation Including Research And Development
StockBasedCompensationIncludingResearchAndDevelopment
0 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7557 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
169 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
16464 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
77524 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
16234 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
77320 usd
CY2022 us-gaap Interest Expense
InterestExpense
417 usd
CY2021 us-gaap Interest Expense
InterestExpense
3111 usd
CY2022 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
166 usd
CY2021 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-26 usd
CY2022 us-gaap Other Expenses
OtherExpenses
47 usd
CY2021 us-gaap Other Expenses
OtherExpenses
1926 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16281 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
79246 usd
CY2022 us-gaap Profit Loss
ProfitLoss
16281 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-79245 usd
CY2022 apcx Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-1.00
CY2021 apcx Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-66.20
CY2022 apcx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
16246000 shares
CY2021 apcx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
1197000 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-8195 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-79245 usd
CY2021 apcx Imputed Interest
ImputedInterest
10 usd
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
10507 usd
CY2021 apcx Issuance Of Options For Capitalized Prepaid Software Development And License
IssuanceOfOptionsForCapitalizedPrepaidSoftwareDevelopmentAndLicense
67527 usd
CY2021 apcx Common Stock Issued For Forbearance Amount
CommonStockIssuedForForbearanceAmount
68 usd
CY2021 apcx Common Stock Issued For Services With Warrant Issuance
CommonStockIssuedForServicesWithWarrantIssuance
29 usd
CY2021 apcx Common Stock Issued For Convertible Notes Payable One Amount
CommonStockIssuedForConvertibleNotesPayableOneAmount
5266 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
44 usd
CY2022 us-gaap Profit Loss
ProfitLoss
16281 usd
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
7706 usd
CY2022 apcx Common Stock Issued For Forbearances
CommonStockIssuedForForbearances
10 usd
CY2022 apcx Option Exercise Amount
OptionExerciseAmount
20 usd
CY2022 apcx Common Stock Issued For Patents
CommonStockIssuedForPatents
407 usd
CY2022 apcx Net Proceeds From Sale Of Offering Amount
NetProceedsFromSaleOfOfferingAmount
13395 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7424 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16281 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
79246 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
7706 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
5323 usd
CY2022 apcx Common Stock Issued For Forbearances Two
CommonStockIssuedForForbearancesTwo
-10 usd
CY2022 apcx Gain On Relief Of Accrued Interest
GainOnReliefOfAccruedInterest
150 usd
CY2021 apcx Stock Issued For Exercise Of Warrants
StockIssuedForExerciseOfWarrants
29 usd
CY2021 apcx Stock Issued For Purchase Of Judgment
StockIssuedForPurchaseOfJudgment
-1000 usd
CY2022 apcx Stock Issued For Excess Fair Value Of Equity
StockIssuedForExcessFairValueOfEquity
904 usd
CY2021 apcx Stock Issued For Excess Fair Value Of Equity
StockIssuedForExcessFairValueOfEquity
68956 usd
CY2021 apcx Excess Fair Market Value Of Shares Issued Recorded As Interest Expense
ExcessFairMarketValueOfSharesIssuedRecordedAsInterestExpense
2706 usd
CY2021 apcx Imputed Interest On Notes Payable
ImputedInterestOnNotesPayable
-10 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
47 usd
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
297 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
405 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1106 usd
CY2022 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-166 usd
CY2021 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
26 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-38 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
88 usd
CY2022 apcx Pepaid License Costs
PepaidLicenseCosts
180 usd
CY2021 apcx Pepaid License Costs
PepaidLicenseCosts
-909 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
909 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
928 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
104 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
240 usd
CY2021 apcx Increase Decrease In Right Of Use Asset And Liability
IncreaseDecreaseInRightOfUseAssetAndLiability
9 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8199 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1825 usd
CY2022 apcx Payments For Softwares
PaymentsForSoftwares
1789 usd
CY2021 apcx Payments For Softwares
PaymentsForSoftwares
-1177 usd
CY2022 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
2 usd
CY2021 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
8 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1791 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1185 usd
CY2021 apcx Payments For Prepaid Offering Costs
PaymentsForPrepaidOfferingCosts
92 usd
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
-34 usd
CY2022 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
15005 usd
CY2022 apcx Offering Costs Paid
OfferingCostsPaid
1517 usd
CY2022 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
14 usd
CY2022 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
50 usd
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
20 usd
CY2021 us-gaap Proceeds From Repurchase Of Redeemable Preferred Stock
ProceedsFromRepurchaseOfRedeemablePreferredStock
3087 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13444 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2961 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3454 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-49 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3462 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8 usd
CY2022 apcx Common Stock Issued For Forbearances One
CommonStockIssuedForForbearancesOne
-10 usd
CY2021 apcx Common Stock Issued For Conversion Of Accounts Payable
CommonStockIssuedForConversionOfAccountsPayable
206 usd
CY2021 apcx Common Stock Issued Convertible Notes Accrued Interest And Derivative Liabilities
CommonStockIssuedConvertibleNotesAccruedInterestAndDerivativeLiabilities
2336 usd
CY2022 apcx Relief Of Antidilution Liability Through Issuance Of Common Stock
ReliefOfAntidilutionLiabilityThroughIssuanceOfCommonStock
2124 usd
CY2022 apcx Issuance Of Stock For Prepaid Services
IssuanceOfStockForPrepaidServices
269 usd
CY2022 apcx Issuance Of Stock For Intangible Assets
IssuanceOfStockForIntangibleAssets
407 usd
CY2021 apcx Common Stock And Options Issued For Capitalized Software And Licensing Costs
CommonStockAndOptionsIssuedForCapitalizedSoftwareAndLicensingCosts
5013 usd
CY2021 apcx Common Stock Issued With Forbearance Agreements Recorded As Discount
CommonStockIssuedWithForbearanceAgreementsRecordedAsDiscount
68 usd
CY2023 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
9.5 to 1
CY2023 apcx Sale Of Stock Units
SaleOfStockUnits
4.15
CY2023 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
3614458 shares
CY2023 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
13400000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zpybuC3zfHB6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_868_zngfSVarLvs2">Use of Estimates</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"> </p><p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated liabilities related to various vendors in which communications have ceased, contingent liabilities, amortization of capitalized software costs, licenses costs and patents, and realization of deferred tax assets. Actual results could differ from those estimates.</p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_ztfyVYmqaYu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_869_zWjof7JraEVk">Concentration of Credit Risk</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits of $250,000 per institution that pays Federal Deposit Insurance Corporation (“FDIC”) insurance premiums. The Company has never experienced any losses related to these balances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accounts receivable from merchant services are paid by the financial institutions on a monthly basis. For the year ended December 31, 2022, there is no merchant (customer) representing a significant amount of total revenue. For the years ended December 31, 2021, the one merchant (customer) represented approximately 11% of the total revenues. The loss of this customer would not have significant impact on the Company’s operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
400053 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.56
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1089868 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.00
CY2022Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
433 usd
CY2021Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
599 usd
CY2022 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
7600000 usd
CY2021 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
169 usd
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
21491 shares
CY2021 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
236 usd
CY2022 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
66 usd
CY2022 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
225000 shares
CY2022 apcx Diluted Income Per Share
DilutedIncomePerShare
6254396 shares
CY2021 apcx Diluted Income Per Share
DilutedIncomePerShare
1263543 shares
CY2022Q4 us-gaap Auction Market Preferred Securities Stock Series Liquidation Value
AuctionMarketPreferredSecuritiesStockSeriesLiquidationValue
1148 usd
CY2021Q4 us-gaap Auction Market Preferred Securities Stock Series Liquidation Value
AuctionMarketPreferredSecuritiesStockSeriesLiquidationValue
1148 usd
CY2022Q4 us-gaap Convertible Debt
ConvertibleDebt
177620 usd
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
175632 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
4275464 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
31579 usd
CY2022Q4 us-gaap Option Indexed To Issuers Equity Redeemable Stock Redemption Requirements Amount1
OptionIndexedToIssuersEquityRedeemableStockRedemptionRequirementsAmount1
1089868 usd
CY2021Q4 us-gaap Option Indexed To Issuers Equity Redeemable Stock Redemption Requirements Amount1
OptionIndexedToIssuersEquityRedeemableStockRedemptionRequirementsAmount1
1055184 usd
CY2022Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
710296 usd
CY2021Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
0 usd
CY2022Q4 apcx Anti Dilutive Income
AntiDilutiveIncome
6254396 usd
CY2021Q4 apcx Anti Dilutive Income
AntiDilutiveIncome
1263543 usd
CY2022Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
4900000 usd
CY2022 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
407 usd
CY2022 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
96 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
311 usd
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
42105 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.10
CY2022Q4 apcx Accrued Interest Third Parties
AccruedInterestThirdParties
1436 usd
CY2021Q4 apcx Accrued Interest Third Parties
AccruedInterestThirdParties
1420 usd
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
311 usd
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
294 usd
CY2022Q4 apcx Accrued Residuals
AccruedResiduals
31 usd
CY2021Q4 apcx Accrued Residuals
AccruedResiduals
98 usd
CY2022Q4 apcx Antidilution Provision
AntidilutionProvision
72 usd
CY2021Q4 apcx Antidilution Provision
AntidilutionProvision
1290 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
20 usd
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
34 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1870 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3136 usd
CY2021 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
1300000 usd
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
72 usd
CY2022Q4 us-gaap Net Investment Hedge Derivative Liabilities At Fair Value
NetInvestmentHedgeDerivativeLiabilitiesAtFairValue
390 usd
CY2022Q4 us-gaap Fair Value Option Loans Held As Assets Aggregate Amount In Nonaccrual Status
FairValueOptionLoansHeldAsAssetsAggregateAmountInNonaccrualStatus
166 usd
CY2021Q4 us-gaap Fair Value Option Loans Held As Assets Aggregate Amount In Nonaccrual Status
FairValueOptionLoansHeldAsAssetsAggregateAmountInNonaccrualStatus
26 usd
CY2022 apcx Derivative Liability Convertible Notes Begining Balance
DerivativeLiabilityConvertibleNotesBeginingBalance
599 usd
CY2022 apcx Change In Fair Value
ChangeInFairValue
-166 usd
CY2022 apcx Derivative Liability Convertible Notes Ending Balance
DerivativeLiabilityConvertibleNotesEndingBalance
433 usd
CY2021 apcx Derivative Liability Convertible Notes Begining Balance
DerivativeLiabilityConvertibleNotesBeginingBalance
598 usd
CY2021 apcx Change In Fair Value
ChangeInFairValue
26 usd
CY2021 apcx Change In Fair Value Due To Conversion
ChangeInFairValueDueToConversion
-25 usd
CY2021 apcx Derivative Liability Convertible Notes Ending Balance
DerivativeLiabilityConvertibleNotesEndingBalance
599 usd
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
88 usd
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
90 usd
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
7 usd
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
185 usd
CY2022Q4 apcx Imputed Interests
ImputedInterests
22 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
163 usd
CY2022 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
85 usd
CY2021 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
61 usd
CY2022 apcx Engagement Fee
EngagementFee
100 usd
CY2022 apcx License Subscription Fee
LicenseSubscriptionFee
750 usd
CY2022 apcx Annual Maintenance Subscription Fee
AnnualMaintenanceSubscriptionFee
113 usd
CY2022 apcx Implementation Fee
ImplementationFee
325 usd
CY2022 apcx Infrastructure Implementation Fee
InfrastructureImplementationFee
65 usd
CY2022 apcx Training Fee
TrainingFee
50 usd
CY2022 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
1403 usd
CY2022 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
371846 shares
CY2021 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
69532 shares
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
162914 shares
CY2022Q4 apcx Convertible Notes Payable One
ConvertibleNotesPayableOne
857698 usd
CY2022Q4 apcx Convertible Notes Payable Related Parties
ConvertibleNotesPayableRelatedParties
395630 usd
CY2022Q4 apcx Accrued Interest
AccruedInterest
674199 usd
CY2022Q4 apcx Accrued Interest Related Parties
AccruedInterestRelatedParties
383964 usd
CY2022Q4 apcx Excess Fair Value Of Equity Issuance
ExcessFairValueOfEquityIssuance
816476 usd
CY2022Q4 apcx Excess Fair Value Of Equity Issuance Related Parties
ExcessFairValueOfEquityIssuanceRelatedParties
1911769 usd
CY2022Q4 apcx Equity Amount
EquityAmount
5039736 usd
CY2022 apcx Market Value Of Common Stock On Issuance Date Minimun
MarketValueOfCommonStockOnIssuanceDateMinimun
0.64
CY2022 apcx Market Value Of Common Stock On Issuance Date Maximum
MarketValueOfCommonStockOnIssuanceDateMaximum
12.45
CY2022 apcx Exercise Price Minimun
ExercisePriceMinimun
0.64
CY2022 apcx Exercise Price Maximum
ExercisePriceMaximum
12.04
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
4.15 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
4.42 pure
CY2022 apcx Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term6
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm6
P5Y
CY2022 apcx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate1
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
0.11 pure
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1055184 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.62
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
476842 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.36
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Period Increase Decrease
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease
991896 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
7.22
CY2021 apcx Market Value Of Common Stock On Issuance Date Minimun
MarketValueOfCommonStockOnIssuanceDateMinimun
5.34
CY2021 apcx Market Value Of Common Stock On Issuance Date Maximum
MarketValueOfCommonStockOnIssuanceDateMaximum
33.25
CY2021 apcx Exercise Price Minimun
ExercisePriceMinimun
0.095
CY2021 apcx Exercise Price Maximum
ExercisePriceMaximum
19.34
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
4.50 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
4.52 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0011 pure
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4100000 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2400000 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1700000 usd
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
193 usd

Files In Submission

Name View Source Status
apcx-20221231_cal.xml Edgar Link unprocessable
0001903596-23-000201-index-headers.html Edgar Link pending
0001903596-23-000201-index.html Edgar Link pending
0001903596-23-000201.txt Edgar Link pending
0001903596-23-000201-xbrl.zip Edgar Link pending
apcx-20221231.xsd Edgar Link pending
apcx_10k.htm Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
apcx-20221231_def.xml Edgar Link unprocessable
apcx-20221231_lab.xml Edgar Link unprocessable
apcx-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
apcx_10k_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending